Aberrant expression of the TLX1/HOX11 proto-oncogene is associated with a significant subset of Tcell acute lymphoblastic leukemias (T-ALL). Yet the manner in which TLX1contributes to oncogenesis is not fully understood. Since, typically, interactions of HOX and TALE homeodomain proteins are determinant of HOX function, and HOX/MEIS co-expression has been shown to accelerate some leukemias, we systematically examined whether TLX1 interacts with MEIS and PBX proteins. Here, we report that TLX1 and MEIS proteins both interact and are co-expressed in T-ALL, and suggest that co-operation between TLX1 and MEIS proteins may have a significant role in T-cell leukemogenesis.
Introduction
Aberrant expression of the TLX1/HOX11 NK-like homeobox gene is strongly associated with T-cell acute lymphoblastic leukemia (T-ALL), where it occurs at both high and low levels owing to translocations involving TCR loci and as yet undefined events, respectively [1] , [2] and [3] . In sharp contrast, TLX1 expression is not detected in B-lineage ALL or in primary lymphocytes [1] , [4] and [5] . This specificity of TLX1 expression in a high proportion of T-ALL cases argues that TLX1 is important to oncogenesis in these patients.
Studies using murine models of TLX1-driven tumorigenesis have provided ancillary evidence of its oncogenic potential. TLX1 can immortalise hematopoietic precursors [6] , block cell differentiation [6] , [7] and [8] and prompt the development of B-cell lymphomas after long latency [9] . Altogether, this body of evidence suggests that TLX1 over-expression in lymphocytes contributes to cellular immortalisation and potentiates oncogenesis. However, extended latency periods indicate that TLX1 expression alone is insufficient for tumorigenesis, and that additional factors or events are required for malignant transformation.
Much attention has been focused on the function of the TLX1 homeoprotein in order to understand its oncogenic role. TLX1 is a DNA-binding homeodomain transcription factor [10] that is essential for splenogenesis in the developing animal [11] , and which regulates the expression of target genes such as Aldh1a1 and Wt1 [12] and [13] . In addition, TLX1 has been implicated in non-transcriptional oncogenic mechanisms, namely G1/S cell cycle progression through inhibition of protein phosphatases 1 and 2A [14] and [15] and promotion of chromosome missegregation through cooperation with factors such as the Ubr1 ubiquitin ligase [16] .
A number of studies on oncogenic homeoprotein function have concluded that co-operating proteins are significant for HOX function, as they increase the affinity and specificity of DNA binding of the heterodimer compared to the HOX protein alone [17] and [18] . TLX1 has been detected in transcriptional complexes with a number of factors including CTF1, CBP and Gro/TLE1 [19] , [20] and [21] . One of the most abundant and important classes of HOX co-factors is the TALE homeodomain superclass, comprised of PBX, MEIS and PREP proteins [22] .
Heterodimeric and trimeric complexes between HOX, PBX and MEIS proteins and co-operation between HOX and TALE genes is central to the development of many leukemias [23] , [24] and [25] .
Initial in vitro studies have shown that TLX1 can interact with the PBX TALE homeodomain family [26] . But while PBX-HOX interactions are important for the function of HOX proteins in normal cellular regulatory processes and in oncogenesis, so too are MEIS-HOX interactions [25] .
We hypothesized that if TLX1 interacts with MEIS homeodomain proteins, such interactions could be significant for the onset or maintenance of TLX1-dependent oncogenesis. Therefore, this study investigated whether TLX1, like members of HOX paralog groups 9 and 10, can interact with MEIS, as well as PBX proteins. Our results demonstrated that TLX1 and MEIS1/2 not only interact, but also are co-expressed in T-ALL and therefore have the potential to co-operate in leukemogenesis.
Materials and methods

Yeast two-hybrid interactions
Full-length coding sequences for human TLX1, MEIS1, MEIS2A, MEIS2B and PBX were amplified from cell line cDNA or plasmid constructs and directionally cloned in-frame into the pGilda bait (Origene, USA) and/or pJG4-5 prey vectors of the LexA-based two-hybrid system. Partial fragments of TLX1 were also expressed as two-hybrid bait or prey fusions from the same vectors: TLX1-AD (51-331aa); TLX1N (1-196aa); TLX1C (190-331aa); TLX1H (151-273aa). All clones were verified by sequence analysis. In a LexA-based two-hybrid system, haploid Saccharomyces cerevisiae (S. cerevisiae) strains of opposite mating types containing baits (strain EGY48, pre-transformed with the LacZ reporter pSH18-34) or preys (strain RFY206) were mated in grid format [27] , and then replica-plated to selective minimal media: yeast synthetic minimal media containing X-gal, and lacking uracil, histidine, tryptophan (UHW − ), and containing either 2% dextrose or 2% raffinose/2% galactose for induction of two-hybrid fusion proteins. For interaction experiments using TLX1 baits, two-hybrid fusion proteins were induced with 0.2% galactose to minimise autoactivation of the LacZ reporter by TLX1 baits. Activation of the LacZ reporter was observed after incubation on selective minimal media from 2 days onwards, and was scored by relative color intensity. Scorings were corrected for background activation (bait construct + prey vector) before tabulation.
Co-immunoprecipitation (Co-IP) from yeast cells S. cerevisiae diploids containing different bait and prey combinations were inoculated into UHW − 2%
raffinose broth for overnight growth. These cultures were used to seed YPR (standard YPD medium with 2% dextrose replaced by 2% raffinose) at 0.5 × 10 7 cells/ml. YPR cultures were incubated for 6 h to achieve log phase growth (2 × 10 7 cells/ml), whereupon expression of tagged bait and prey proteins antibody. Controls were performed in parallel using α-rat-Dynalbeads without primary antibody.
Co-immunoprecipitation from transfected mammalian cells
Human coding sequences for TLX1 and MEIS were cloned, with a 3′ HA tag, into the pEF-BOS vector; TLX1 was also cloned into the same vector without the HA tag. HSB-2 T-lymphoblastoid cells analysis, membranes were probed with α-TLX1 antibody used at 1:4000 dilution [28] .
RT-PCR
Pediatric T-ALL cell lines [29] , including PER-117 stably transfected with TLX1 [30] , were screened 
Real-time quantitative RT-PCR
The real-time quantitative RT-PCR methodology, RNA extraction and cDNA synthesis have been previously described in detail [2] , along with the primers and probes used for TLX1 analysis. Primers and 6FAM-labelled probe sets for MEIS genes were as follows. MEIS1: fwd primer 5′
GCTCCTCTGTCAATGACGCTTT; rev primer 5′ CATTTCTCAAAAATCAGTGCTAAGAGA;
probe ATGCCATTTATGGACACCCCCTCTTCC. MEIS2: fwd primer 5′
CAGTATGGGATCCGCTGTCA; rev primer 5′ AAACAACGGGTGCCCATAGA; probe CGCGTCCTTGTCCCGCTTCAA. The cohort of pediatric T-ALL patients has been previously described [31] ; IRB approval and parental consents were obtained prior to collection of patient specimens.
Results
TLX1 interacts with multiple TALE proteins
TALE homeoproteins have previously been implicated as partners of TLX1 [26] , [32] and [33] . To systematically assess the comparative ability of TALE family members to interact with TLX1, a yeast two-hybrid system was employed, since the relative ranking of protein interaction strength in twohybrid experiments, judged by reporter activation levels, has been reported generally to correlate with in vitro measurements of the affinity of protein interaction [34] . SCL and GATA3, important non-homeodomain transcription factors in hematopoiesis and leukemogenesis, were included as negative controls. TLX1/TALE interactions were tested in both orientations (TLX1 constructs as both bait and prey), since protein interactions can be affected by the orientation of the assessment [34] .
However, full-length TLX1 was only used as a prey protein because it was found to strongly autoactivate when used as bait. Overall, multiple TLX1-TALE interactions were found, which were of differing strengths. The results of independent mating experiments were averaged and are summarised in Table 1 while Fig. 1 shows a representative interaction test involving TLX1 with MEIS1 and 2A.
These yeast-mating experiments confirmed TLX1 interaction with PBX1/2/3 proteins and also identified the two shorter isoforms of PBX3 (PBX3C and PBX3D) as novel TLX1 partners. This analysis also specifically identified MEIS1 and MEIS2 as protein partners for TLX1. Indeed, MEIS2, together with PBX3B, appeared to be the highest affinity TLX1 interactors in the panel of TALE proteins tested. The observed reporter activation by MEIS2/TLX1 and PBX3B/TLX1 was comparable to that of SCL/LMO2 complexes in similar experiments, signifying that these TLX1 interactions may be of similar affinity to SCL/LMO2 interaction. Deletion constructs, included to map the TLX1 interaction domains, showed that the amino-terminus of TLX1 is required for interaction with MEIS proteins and that the homeodomain plus YPWMR motif is required for interaction with PBX proteins (Table 1 and Fig. 1 ).
Confirmation of MEIS proteins as TLX1 interactors
Strong interaction between TLX1 and MEIS proteins was a novel finding. To confirm the yeast two- 
Co-expression of TLX1 and MEIS in T-ALL cell lines
For TLX1 and MEIS proteins to have functional relevance in leukemia, it is not only necessary that they interact, but also that the proteins are co-expressed in leukemic cells. Consequently, using RT-PCR, we assessed the co-expression of TLX1 and MEIS mRNA in a panel of T-ALL cell lines, normal lymphoid cell populations, and a positive control cell line for MEIS expression, K562 ( Fig. 4A ).
PER-255 and ALL-SIL are T-ALL cell lines that endogenously express TLX1 as a result of TCR-TLX1 translocations. Here, they were also shown to express both MEIS1 and MEIS2 transcripts.
Indeed, overall, MEIS expression in the T-ALL cell line panel was high,
with MEIS1 and MEIS2expressed, respectively, in 7/9 (78%) and 6/9 (67%) of the cell lines tested.
Both MEIS genes were also expressed in mature T-cells, as well as tonsil, peripheral blood lymphocytes (PBLs), and the cell line K562. One T-ALL cell line, PER-117, had also been stably transfected with TLX1. RT-PCR analysis showed that both MEIS1 and MEIS2transcripts were expressed before and after TLX1 transfection (Fig. 4A) , establishing that TLX1 expression did not silence expression of MEIS1 or MEIS2.
Co-expression of TLX1 and MEIS in primary leukemic specimens from T-ALL patients
The co-expression studies were extended to include patient specimens. Forty independent pediatric T- 
Discussion
Identifying the interacting protein components of TLX1-containing complexes can provide insight into its functional networks and thereby help to elucidate its role in tumorigenesis [14] , [19] , [20] , [21] , [26] and [33] . Abundant research has shown that HOX/MEIS and HOX/MEIS/PBX protein interactions play critical roles in both development and oncogenesis [24] , [25] and [35] . Accordingly, we investigated whether PBX and MEIS proteins could function as co-factors of the TLX1 homeoprotein. Using yeast two-hybrid interaction studies the interactions of TLX1 with MEIS were found to be of comparable affinity to interactions of TLX1 with various PBX proteins tested in parallel. Moreover, co-IP studies confirmed MEIS proteins as novel partners for the TLX1 oncoprotein. Consistent with the principles established for HOX/TALE interactions, TLX1 interaction with MEIS proteins required the amino-terminal portion of the TLX1 protein (excluding the first 50 amino acids), while interactions with PBX proteins required both the homeodomain and YPWMR motif of TLX1.
Previously, PBX proteins, including the long isoforms of PBX1/2/3, were reported to interact with TLX1 in gel-shift assays [26] . The yeast interaction results reported here agree with these findings, and expand these TLX1 interactors to include the shorter PBX3 isoforms, PBX3C and PBX3D.
However, Allen et al. [26] were unable to detect TLX1 interaction with MEIS proteins on DNA.
Technical considerations are the likely reason for the difference in results. For example, gel-shift assays require optimal DNA sequences to bind protein complexes successfully.
Having established that MEIS proteins are novel partners for TLX1, we investigated the coexpression patterns of TLX1, MEIS1 and MEIS2 in T-ALL cell lines and patient specimens.
Both TLX1-expressing cell lines co-expressed both MEIS genes, and nearly all (90%) of the TLX1-positive T-ALL patient specimens also expressed either MEIS1, MEIS2, or both genes. The coexpression of MEIS with TLX1 in T-lineage neoplasms potentially enables the interaction of these proteins to play a pivotal role in TLX1-driven oncogenesis. In the oncogenic collaboration between HOX and MEIS proteins, there is mounting evidence that the initiating oncogenic factor is the aberrant expression of the HOX gene. Also called the "co-operative differentiation arrest" model [36] , this theory proposes that deregulation of the HOX gene arrests cell differentiation, thus committing the cell to oncogenic transformation along a particular lineage. TLX1 interaction with MEIS proteins could also be of significance in the normal context since, like Meis, Tlx1 is involved in the development of the central nervous system [37] .
In murine models, deregulation of TLX1 alone has failed to recapitulate leukemic disease analogous to the T-ALL phenotype seen in humans [6] , [7] and [9] , indicating a requirement for co-operating factors or events. Similarly, the biological pathways controlled by TLX1 are only partially
characterized, yet are critical to understanding TLX1 function. Notably, MEIS expression in T-lineage neoplasms has not been widely examined to date. Instead, the majority of studies have focused on myeloid leukemia, where MEIS proteins can function co-operatively with HOX proteins in leukemogenesis [25] , and neuroblastoma [38] , where TLX1 transcripts have also been identified [39] .
Here, assessment of expression of TLX1 and MEIS genes in T-ALL cell lines and primary patient specimens established a strong pattern of co-expression and suggested that TLX1 and MEIS have the potential to co-operate in T-cell leukemogenesis. Further studies are now warranted to functionally confirm whether MEIS factors are critical co-factors of normal and/or oncogenic TLX1 function.
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